Published in Nat Rev Immunol on November 01, 2007
Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol (2009) 4.90
The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting. Nat Rev Drug Discov (2008) 3.25
Reimagining Alzheimer's disease--an age-based hypothesis. J Neurosci (2010) 2.12
Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci (2012) 2.01
Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Circ Res (2012) 1.85
The methylcytosine dioxygenase Tet2 promotes DNA demethylation and activation of cytokine gene expression in T cells. Immunity (2015) 1.79
Regulation of innate and adaptive immunity by Notch. Nat Rev Immunol (2013) 1.58
IL-10-producing NKT10 cells are a distinct regulatory invariant NKT cell subset. J Clin Invest (2014) 1.48
IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis. J Immunol (2010) 1.46
The relevance of animal models in multiple sclerosis research. Pathophysiology (2011) 1.40
Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol Ther (2010) 1.39
The role of microbiome in central nervous system disorders. Brain Behav Immun (2013) 1.34
To fold or not to fold: modulation and consequences of Hsp90 inhibition. Future Med Chem (2009) 1.29
Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases. Front Neuroendocrinol (2008) 1.23
Neuron-glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage. Open Biol (2013) 1.21
Transcription of Il17 and Il17f is controlled by conserved noncoding sequence 2. Immunity (2012) 1.18
CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytes. Mol Ther (2012) 1.12
Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet. J Neuroinflammation (2011) 1.11
An intestinal commensal symbiosis factor controls neuroinflammation via TLR2-mediated CD39 signalling. Nat Commun (2014) 1.11
Notch ligand delta-like 4 blockade alleviates experimental autoimmune encephalomyelitis by promoting regulatory T cell development. J Immunol (2011) 1.06
The immunomodulatory action of sialostatin L on dendritic cells reveals its potential to interfere with autoimmunity. J Immunol (2009) 1.05
Revisiting the Mechanisms of CNS Immune Privilege. Trends Immunol (2015) 1.04
Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis. Brain (2009) 1.03
Pathogenic and regulatory roles for B cells in experimental autoimmune encephalomyelitis. Autoimmunity (2012) 1.02
Fusion of metabolomics and proteomics data for biomarkers discovery: case study on the experimental autoimmune encephalomyelitis. BMC Bioinformatics (2011) 1.01
Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models. Biochim Biophys Acta (2010) 1.00
CNS-derived CCL21 is both sufficient to drive homeostatic CD4+ T cell proliferation and necessary for efficient CD4+ T cell migration into the CNS parenchyma following Toxoplasma gondii infection. Brain Behav Immun (2010) 0.99
A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J Neuroimmunol (2010) 0.99
Cutting edge: IL-6-dependent autoimmune disease: dendritic cells as a sufficient, but transient, source. J Immunol (2012) 0.99
Brain leukocyte infiltration initiated by peripheral inflammation or experimental autoimmune encephalomyelitis occurs through pathways connected to the CSF-filled compartments of the forebrain and midbrain. J Neuroinflammation (2012) 0.98
Vasoactive intestinal peptide loss leads to impaired CNS parenchymal T-cell infiltration and resistance to experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (2010) 0.97
Conditional ablation of astroglial CCL2 suppresses CNS accumulation of M1 macrophages and preserves axons in mice with MOG peptide EAE. J Neurosci (2014) 0.96
MMP-28 as a regulator of myelination. BMC Neurosci (2008) 0.95
Modeling multiple sclerosis in laboratory animals. Semin Immunopathol (2009) 0.94
Role of toll-like receptors in multiple sclerosis. Am J Clin Exp Immunol (2013) 0.94
The contribution of immune and glial cell types in experimental autoimmune encephalomyelitis and multiple sclerosis. Mult Scler Int (2014) 0.93
Restoring the balance between disease and repair in multiple sclerosis: insights from mouse models. Dis Model Mech (2010) 0.92
Vitamin D Actions on CD4(+) T Cells in Autoimmune Disease. Front Immunol (2015) 0.91
Inhibition of fatty acid metabolism ameliorates disease activity in an animal model of multiple sclerosis. Sci Rep (2011) 0.89
Multiple Sclerosis and T Lymphocytes: An Entangled Story. J Neuroimmune Pharmacol (2015) 0.89
Mouse models of neurological disorders: a view from the blood-brain barrier. Biochim Biophys Acta (2009) 0.88
Understanding disease processes in multiple sclerosis through magnetic resonance imaging studies in animal models. Neuroimage Clin (2014) 0.88
ICAM-1: isoforms and phenotypes. J Immunol (2014) 0.87
Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design. Comp Med (2009) 0.87
Neuroprotective action of lithium in disorders of the central nervous system. Zhong Nan Da Xue Xue Bao Yi Xue Ban (2011) 0.87
Experimental Autoimmune Encephalomyelitis in Mice. Methods Mol Biol (2016) 0.86
The CCL2 synthesis inhibitor bindarit targets cells of the neurovascular unit, and suppresses experimental autoimmune encephalomyelitis. J Neuroinflammation (2012) 0.86
Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS. Cell Immunol (2013) 0.85
Immune modulating peptides for the treatment and suppression of multiple sclerosis. Clin Immunol (2012) 0.84
Fundamental differences in the dynamics of CNS lesion development and composition in MP4- and MOG peptide 35-55-induced experimental autoimmune encephalomyelitis. Clin Immunol (2008) 0.84
Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models. Inflammopharmacology (2014) 0.84
Silencing IFN-γ binding/signaling in astrocytes versus microglia leads to opposite effects on central nervous system autoimmunity. J Immunol (2015) 0.83
Oligodendrocyte regeneration: Its significance in myelin replacement and neuroprotection in multiple sclerosis. Neuropharmacology (2015) 0.83
Modelling biological behaviours with the unified modelling language: an immunological case study and critique. J R Soc Interface (2014) 0.83
Tolerogen-induced interferon-producing killer dendritic cells (IKDCs) protect against EAE. J Autoimmun (2011) 0.83
Altered thymic selection and increased autoimmunity caused by ectopic expression of DRAK2 during T cell development. J Immunol (2009) 0.82
Autoimmunity and inflammation: murine models and translational studies. Mamm Genome (2011) 0.82
The unfolded protein response in multiple sclerosis. Front Neurosci (2015) 0.82
Mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis. Int J Mol Sci (2012) 0.82
CD8(+) T Cells Are Required For Glatiramer Acetate Therapy in Autoimmune Demyelinating Disease. PLoS One (2013) 0.82
The meninges: new therapeutic targets for multiple sclerosis. Transl Res (2014) 0.81
Astrocytic IL-6 Influences the Clinical Symptoms of EAE in Mice. Brain Sci (2016) 0.81
Substrain differences reveal novel disease-modifying gene candidates that alter the clinical course of a rodent model of multiple sclerosis. J Immunol (2010) 0.81
Agent-Based Modeling in Systems Pharmacology. CPT Pharmacometrics Syst Pharmacol (2015) 0.81
Whole-Body In Vivo Monitoring of Inflammatory Diseases Exploiting Human Interleukin 6-Luciferase Transgenic Mice. Mol Cell Biol (2015) 0.81
Chatting with the neighbors: crosstalk between Rho-kinase (ROCK) and other signaling pathways for treatment of neurological disorders. Front Neurosci (2015) 0.81
Toll-Like Receptors in the Pathogenesis of Autoimmune Diseases. Adv Pharm Bull (2015) 0.81
An overview of the lagomorph immune system and its genetic diversity. Immunogenetics (2015) 0.81
Precision Medicine in Multiple Sclerosis: Future of PET Imaging of Inflammation and Reactive Astrocytes. Front Mol Neurosci (2016) 0.80
Multiple sclerosis: molecular mechanisms and therapeutic opportunities. Antioxid Redox Signal (2013) 0.80
Stage-Specific Role of Interferon-Gamma in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis. Front Immunol (2015) 0.80
Comparison of a classical Th1 bacteria versus a Th17 bacteria as adjuvant in the induction of experimental autoimmune encephalomyelitis. J Neuroimmunol (2011) 0.79
EphA4 receptor tyrosine kinase is a modulator of onset and disease severity of experimental autoimmune encephalomyelitis (EAE). PLoS One (2013) 0.79
G proteins Gαi1/3 are critical targets for Bordetella pertussis toxin-induced vasoactive amine sensitization. Infect Immun (2013) 0.78
Notch signaling and T-helper cells in EAE/MS. Clin Dev Immunol (2013) 0.78
Natural killer T cells in multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis. Immunology (2015) 0.78
Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levels. Brain Behav Immun (2013) 0.78
Bystander-mediated stimulation of proteolipid protein-specific regulatory T (Treg) cells confers protection against experimental autoimmune encephalomyelitis (EAE) via TGF-β. J Neuroimmunol (2012) 0.78
Effects of isoxazolo-pyridinone 7e, a potent activator of the Nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice. PLoS One (2014) 0.78
Pharmacokinetics and modeling of immune cell trafficking: quantifying differential influences of target tissues versus lymphocytes in SJL and lipopolysaccharide-treated mice. J Neuroinflammation (2012) 0.77
Experimental autoimmune encephalomyelitis development is aggravated by Candida albicans infection. J Immunol Res (2015) 0.77
PI3Kγ drives priming and survival of autoreactive CD4(+) T cells during experimental autoimmune encephalomyelitis. PLoS One (2012) 0.77
Oxidative signaling in experimental autoimmune encephalomyelitis. Toxicol Sci (2010) 0.77
Variable effects of cyclophosphamide in rodent models of experimental allergic encephalomyelitis. Clin Exp Immunol (2009) 0.77
Macrophages in neuroinflammation: role of the renin-angiotensin-system. Pflugers Arch (2017) 0.77
Nicotinic acid-mediated activation of both membrane and nuclear receptors towards therapeutic glucocorticoid mimetics for treating multiple sclerosis. PPAR Res (2009) 0.76
Mechanisms and pharmacology of neuropathic pain in multiple sclerosis. Curr Top Behav Neurosci (2014) 0.76
Meningeal Infiltration of the Spinal Cord by Non-Classically Activated B Cells is Associated with Chronic Disease Course in a Spontaneous B Cell-Dependent Model of CNS Autoimmune Disease. Front Immunol (2015) 0.76
PIF* promotes brain re-myelination locally while regulating systemic inflammation- clinically relevant multiple sclerosis M.smegmatis model. Oncotarget (2017) 0.75
Acute Disseminated Encephalomyelitis Following Immunization with Human Papillomavirus Vaccines. Intern Med (2016) 0.75
Tryptophan-2,3-Dioxygenase (TDO) deficiency is associated with subclinical neuroprotection in a mouse model of multiple sclerosis. Sci Rep (2017) 0.75
Advancing Cardiovascular, Neurovascular, and Renal Magnetic Resonance Imaging in Small Rodents Using Cryogenic Radiofrequency Coil Technology. Front Pharmacol (2015) 0.75
Biopharmaceuticals from microorganisms: from production to purification. Braz J Microbiol (2016) 0.75
Murine hypothalamic destruction with vascular cell apoptosis subsequent to combined administration of human papilloma virus vaccine and pertussis toxin. Sci Rep (2016) 0.75
GM-CSF-Producing Th Cells in Rats Sensitive and Resistant to Experimental Autoimmune Encephalomyelitis. PLoS One (2016) 0.75
Double Roles of Macrophages in Human Neuroimmune Diseases and Their Animal Models. Mediators Inflamm (2016) 0.75
Alpha-tocopherol ameliorates experimental autoimmune encephalomyelitis through the regulation of Th1 cells. Iran J Basic Med Sci (2016) 0.75
Autoimmunity and tumor immunology: two facets of a probabilistic immune system. BMC Syst Biol (2014) 0.75
Automated multi-objective calibration of biological agent-based simulations. J R Soc Interface (2016) 0.75